CIURLEO, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.937
EU - Europa 2.868
AS - Asia 1.458
SA - Sud America 472
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 11.774
Nazione #
US - Stati Uniti d'America 6.879
RU - Federazione Russa 1.601
SG - Singapore 554
CN - Cina 454
BR - Brasile 396
SE - Svezia 329
IE - Irlanda 315
HK - Hong Kong 168
DE - Germania 126
IT - Italia 119
VN - Vietnam 109
UA - Ucraina 106
FR - Francia 76
FI - Finlandia 62
GB - Regno Unito 53
IN - India 41
CA - Canada 29
AR - Argentina 24
BD - Bangladesh 23
MX - Messico 21
AT - Austria 16
TR - Turchia 15
PL - Polonia 14
IQ - Iraq 13
CO - Colombia 12
JP - Giappone 12
NL - Olanda 11
BE - Belgio 9
EC - Ecuador 9
VE - Venezuela 9
PK - Pakistan 8
ZA - Sudafrica 8
MA - Marocco 7
PY - Paraguay 7
UY - Uruguay 7
UZ - Uzbekistan 7
JO - Giordania 6
TN - Tunisia 6
ID - Indonesia 5
IL - Israele 5
CI - Costa d'Avorio 4
ES - Italia 4
KE - Kenya 4
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
KR - Corea 3
NP - Nepal 3
PH - Filippine 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
LT - Lituania 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
VC - Saint Vincent e Grenadine 1
Totale 11.774
Città #
Dallas 4.688
Moscow 454
Ashburn 407
Dublin 315
Chandler 306
Singapore 274
Nyköping 215
Jacksonville 192
Hong Kong 165
Beijing 137
San Jose 107
Dearborn 87
The Dalles 66
New York 59
Princeton 54
Dong Ket 52
Lauterbourg 52
Los Angeles 51
Medford 48
Cambridge 45
Boardman 43
Des Moines 41
Messina 33
Munich 31
Buffalo 25
Council Bluffs 25
São Paulo 23
Jinan 21
Ho Chi Minh City 20
Ann Arbor 18
Hebei 17
Nanjing 17
Redondo Beach 17
Tianjin 15
Guangzhou 14
Rio de Janeiro 14
Chennai 13
Vienna 13
Frankfurt am Main 12
Milan 12
Orem 12
Santa Clara 12
Tokyo 12
Wilmington 12
Woodbridge 12
Bremen 11
Warsaw 11
Belo Horizonte 10
Taiyuan 10
Turku 10
Brussels 9
Curitiba 9
Brooklyn 8
Hanoi 8
Hyderabad 8
London 8
Boston 7
Campinas 7
Columbus 7
Lancaster 7
Montreal 7
Seattle 7
Shanghai 7
Taizhou 7
Tashkent 7
Toronto 7
Washington 7
Brasília 6
Catania 6
Changsha 6
Chicago 6
Montevideo 6
Montréal 6
Salvador 6
Shenyang 6
Shenzhen 6
Stockholm 6
Amman 5
Amsterdam 5
Asunción 5
Atlanta 5
Baghdad 5
Contagem 5
Dhaka 5
Helsinki 5
Houston 5
Johannesburg 5
Joinville 5
Nanchang 5
Piracicaba 5
Poplar 5
Abidjan 4
Da Nang 4
Denver 4
Fuzhou 4
Haikou 4
Hefei 4
Istanbul 4
Lappeenranta 4
Mexico City 4
Totale 8.603
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 4.785
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 210
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 208
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 205
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 188
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 187
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 183
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 182
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 177
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 174
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 172
Functional evaluation of awareness in vegetative and minimally conscious state 171
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 168
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 158
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 157
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 150
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 149
Functional connectivity in vegetative state patients 148
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 141
White matter substrates of functional connectivity dynamics in the human brain 140
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 139
Neurophysiological approach in comatose patients 139
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 138
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 137
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 130
Evaluation of olfactory dysfunction in neurodegenerative diseases 128
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 126
The role of brain oscillations in post-stroke motor recovery: an overview 124
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 124
Reality orientation therapy (ROT) in Alzheimer’s disease. 117
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 113
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 104
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 103
Neurogenic ejaculatory disorders: focus on current and future treatments. 103
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 102
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 99
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 98
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 96
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 95
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 92
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 90
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 88
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 87
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 87
The clinical use of quality of life scales in the neurodegenerative diseases 86
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 83
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 83
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 82
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 82
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 81
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 78
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 76
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 74
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 71
Role of statins in the treatment of multiple sclerosis 68
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 67
Identification of common pathogenetic processes between schizophrenia and diabetes mellitus by systems biology analysis 66
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 40
null 37
Neuroanatomical correlates of peripersonal space: bridging the gap between perception, action, emotion and social cognition 34
Totale 11.820
Categoria #
all - tutte 28.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/2022318 2 24 4 6 29 1 53 6 8 14 46 125
2022/20231.087 92 110 43 95 89 122 26 55 408 8 28 11
2023/2024301 19 44 21 34 29 92 1 20 2 14 6 19
2024/20251.170 7 15 38 65 46 23 31 259 323 84 89 190
2025/20268.016 133 1.491 3.392 322 323 804 357 467 453 153 76 45
Totale 11.820